TreeWAS – Variant ID: rs4569005

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.142	0.858	0.000
T43.2 Other and unspecified antidepressants	0.137	0.863	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.128	0.872	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.126	0.874	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.125	0.875	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.124	0.876	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.114	0.886	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.109	0.891	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.109	0.891	0.000
K86.8 Other specified diseases of pancreas	0.000	0.894	0.106
T43.6 Psychostimulants with abuse potential	0.106	0.894	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.104	0.896	0.000
K86 Other diseases of pancreas	0.000	0.896	0.104
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.103	0.897	0.000
T43.9 Psychotropic drug, unspecified	0.102	0.898	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.102	0.898	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.102	0.898	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.101	0.899	0.000
K86.9 Disease of pancreas, unspecified	0.000	0.901	0.099
K86.2 Cyst of pancreas	0.000	0.903	0.097
T36 Poisoning by systemic antibiotics	0.095	0.905	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.093	0.906	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.093	0.907	0.000
K86.1 Other chronic pancreatitis	0.000	0.907	0.093
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.092	0.908	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.090	0.910	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.090	0.910	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.090	0.910	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.090	0.910	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.089	0.911	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.089	0.911	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.089	0.911	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.089	0.911	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.086	0.914	0.000
T38.1 Thyroid hormones and substitutes	0.086	0.914	0.000
T38.9 Other and unspecified hormone antagonists	0.082	0.918	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.082	0.918	0.000
T38.7 Androgens and anabolic congeners	0.082	0.918	0.000
T38.5 Other oestrogens and progestogens	0.082	0.918	0.000
T38.4 Oral contraceptives	0.082	0.918	0.000
T38.2 Antithyroid drugs	0.082	0.918	0.000
T38.0 Glucocorticoids and synthetic analogues	0.082	0.918	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.081	0.919	0.000
K86.3 Pseudocyst of pancreas	0.000	0.920	0.080
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.079	0.921	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.079	0.921	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.079	0.921	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.079	0.921	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.079	0.921	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.079	0.921	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.079	0.921	0.000
T44.0 Anticholinesterase agents	0.079	0.921	0.000
T45.5 Anticoagulants	0.078	0.922	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.075	0.925	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.075	0.925	0.000
T47.7 Emetics	0.075	0.925	0.000
T47.6 Antidiarrhoeal drugs	0.075	0.925	0.000
T47.5 Digestants	0.075	0.925	0.000
T47.4 Other laxatives	0.075	0.925	0.000
T47.3 Saline and osmotic laxatives	0.075	0.925	0.000
T47.2 Stimulant laxatives	0.075	0.925	0.000
T47.0 Histamine H(2)-receptor antagonists	0.075	0.925	0.000
T36.0 Penicillins	0.073	0.927	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.073	0.927	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.073	0.927	0.000
T46.7 Peripheral vasodilators	0.073	0.927	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.073	0.927	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.073	0.927	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.073	0.927	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.071	0.928	0.000
T42.1 Iminostilbenes	0.071	0.929	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.071	0.929	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.070	0.930	0.000
T36.9 Systemic antibiotic, unspecified	0.068	0.932	0.000
T36.8 Other systemic antibiotics	0.068	0.932	0.000
T36.7 Antifungal antibiotics, systemically used	0.068	0.932	0.000
T36.6 Rifamycins	0.068	0.932	0.000
T36.5 Aminoglycosides	0.068	0.932	0.000
T36.4 Tetracyclines	0.068	0.932	0.000
T36.3 Macrolides	0.068	0.932	0.000
T36.2 Chloramphenicol group	0.068	0.932	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.068	0.932	0.000
T40.4 Other synthetic narcotics	0.068	0.932	0.000
T45.2 Vitamins, not elsewhere classified	0.068	0.932	0.000
T42.4 Benzodiazepines	0.068	0.932	0.000
T40.2 Other opioids	0.068	0.932	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.067	0.933	0.000
T45.8 Other primarily systemic and haematological agents	0.067	0.933	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.067	0.933	0.000
T45.6 Fibrinolysis-affecting drugs	0.067	0.933	0.000
T45.4 Iron and its compounds	0.067	0.933	0.000
T45.3 Enzymes, not elsewhere classified	0.067	0.933	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.067	0.933	0.000
T37.5 Antiviral drugs	0.067	0.933	0.000
T37.4 Anthelminthics	0.067	0.933	0.000
T37.3 Other antiprotozoal drugs	0.067	0.933	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.067	0.933	0.000
T37.1 Antimycobacterial drugs	0.067	0.933	0.000
T37.0 Sulphonamides	0.067	0.933	0.000
T46.1 Calcium-channel blockers	0.067	0.933	0.000
T42.0 Hydantoin derivatives	0.066	0.934	0.000
T45.0 Antiallergic and antiemetic drugs	0.066	0.934	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.065	0.935	0.000
T40.8 Lysergide [LSD]	0.065	0.935	0.000
T40.7 Cannabis (derivatives)	0.065	0.935	0.000
T40.5 Cocaine	0.065	0.935	0.000
T40.3 Methadone	0.065	0.935	0.000
T40.1 Heroin	0.065	0.935	0.000
T40.0 Opium	0.065	0.935	0.000
T41.5 Therapeutic gases	0.064	0.935	0.000
T41.4 Anaesthetic, unspecified	0.064	0.935	0.000
T41.3 Local anaesthetics	0.064	0.935	0.000
T41.2 Other and unspecified general anaesthetics	0.064	0.935	0.000
T41.1 Intravenous anaesthetics	0.064	0.935	0.000
T41.0 Inhaled anaesthetics	0.064	0.935	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.064	0.935	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.064	0.935	0.000
T48.5 Anti-common-cold drugs	0.064	0.935	0.000
T48.4 Expectorants	0.064	0.935	0.000
T48.3 Antitussives	0.064	0.935	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.064	0.935	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.064	0.935	0.000
T48.0 Oxytocic drugs	0.064	0.935	0.000
T49.9 Topical agent, unspecified	0.064	0.935	0.000
T49.8 Other topical agents	0.064	0.935	0.000
T49.7 Dental drugs, topically applied	0.064	0.935	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.064	0.935	0.000
T49.5 Ophthalmological drugs and preparations	0.064	0.935	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.064	0.935	0.000
T49.3 Emollients, demulcents and protectants	0.064	0.935	0.000
T49.2 Local astringents and local detergents	0.064	0.935	0.000
T49.1 Antipruritics	0.064	0.935	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.064	0.935	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.064	0.935	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.062	0.938	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.062	0.938	0.000
T42.3 Barbiturates	0.062	0.938	0.000
T42.2 Succinimides and oxazolidinediones	0.062	0.938	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.059	0.941	0.000
T50.8 Diagnostic agents	0.059	0.941	0.000
T50.7 Analeptics and opioid receptor antagonists	0.059	0.941	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.059	0.941	0.000
T50.5 Appetite depressants	0.059	0.941	0.000
T50.4 Drugs affecting uric acid metabolism	0.059	0.941	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.059	0.941	0.000
T50.1 Loop [high-ceiling] diuretics	0.059	0.941	0.000
T50.0 Mineralocorticoids and their antagonists	0.059	0.941	0.000
T40.6 Other and unspecified narcotics	0.058	0.942	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.057	0.943	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.051	0.948	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.950	0.050
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.047	0.953	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.043	0.957	0.000
T39.4 Antirheumatics, not elsewhere classified	0.042	0.957	0.000
T39.2 Pyrazolone derivatives	0.042	0.957	0.000
I67.8 Other specified cerebrovascular diseases	0.041	0.959	0.000
T39.0 Salicylates	0.041	0.959	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.039	0.960	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.039	0.961	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.034	0.966	0.000
T39.1 4-Aminophenol derivatives	0.019	0.981	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.000	0.985	0.015
I67 Other cerebrovascular diseases	0.015	0.985	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.013	0.987	0.000
K83 Other diseases of biliary tract	0.000	0.987	0.013
K85 Acute pancreatitis	0.000	0.987	0.013
K83.1 Obstruction of bile duct	0.000	0.988	0.012
K85.1 Biliary acute pancreatitis	0.000	0.988	0.012
K83.9 Disease of biliary tract, unspecified	0.000	0.989	0.011
K83.8 Other specified diseases of biliary tract	0.000	0.989	0.011
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.000	0.989	0.011
I67.7 Cerebral arteritis, not elsewhere classified	0.011	0.989	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.011	0.989	0.000
I67.5 Moyamoya disease	0.011	0.989	0.000
I67.4 Hypertensive encephalopathy	0.011	0.989	0.000
I67.3 Progressive vascular leukoencephalopathy	0.011	0.989	0.000
I67.1 Cerebral aneurysm, nonruptured	0.010	0.990	0.000
I67.2 Cerebral atherosclerosis	0.010	0.990	0.000
K83.3 Fistula of bile duct	0.000	0.990	0.009
K83.2 Perforation of bile duct	0.000	0.990	0.009
K85.8 Other acute pancreatitis	0.000	0.991	0.009
K85.3 Drug-induced acute pancreatitis	0.000	0.991	0.009
K85.0 Idiopathic acute pancreatitis	0.000	0.991	0.009
K85.9 Acute pancreatitis, unspecified	0.000	0.991	0.009
K83.5 Biliary cyst	0.000	0.992	0.008
K81 Cholecystitis	0.000	0.992	0.008
K85.2 Alcohol-induced acute pancreatitis	0.000	0.992	0.008
K87.1 Disorders of pancreas in diseases classified elsewhere	0.000	0.992	0.008
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.000	0.992	0.008
K83.0 Cholangitis	0.000	0.992	0.008
K81.0 Acute cholecystitis	0.000	0.992	0.008
K83.4 Spasm of sphincter of Oddi	0.000	0.992	0.007
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.007	0.993	0.000
T51.0 Ethanol	0.006	0.994	0.000
I67.9 Cerebrovascular disease, unspecified	0.006	0.994	0.000
R94.3 Abnormal results of cardiovascular function studies	0.006	0.994	0.000
Z30.1 Insertion of (intra-uterine) contraceptive device	0.006	0.994	0.000
K81.9 Cholecystitis, unspecified	0.000	0.995	0.005
K81.8 Other cholecystitis	0.000	0.995	0.005
D72.8 Other specified disorders of white blood cells	0.005	0.995	0.000
C81.9 Hodgkin's disease, unspecified	0.005	0.995	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.005	0.995	0.000
T51 Toxic effect of alcohol	0.005	0.995	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.995	0.005
C81 Hodgkin's disease	0.004	0.996	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.996	0.004
T51.9 Alcohol, unspecified	0.004	0.996	0.000
K74.3 Primary biliary cirrhosis	0.000	0.996	0.004
N80.3 Endometriosis of pelvic peritoneum	0.000	0.996	0.004
K74.5 Biliary cirrhosis, unspecified	0.000	0.996	0.004
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
C88 Malignant immunoproliferative diseases	0.004	0.996	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.004	0.996	0.000
C85.0 Lymphosarcoma	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.004	0.996	0.000
T51.8 Other alcohols	0.004	0.996	0.000
T51.3 Fusel oil	0.004	0.996	0.000
T51.2 2-Propanol	0.004	0.996	0.000
T51.1 Methanol	0.004	0.996	0.000
C81.1 Nodular sclerosis	0.004	0.996	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.004	0.996	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
K74.1 Hepatic sclerosis	0.000	0.997	0.003
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
Z63.4 Disappearance and death of family member	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
S72.00 Fracture of neck of femur (closed)	0.003	0.997	0.000
C93 Monocytic leukaemia	0.003	0.997	0.000
R94 Abnormal results of function studies	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
C95 Leukaemia of unspecified cell type	0.003	0.997	0.000
K74.0 Hepatic fibrosis	0.000	0.997	0.003
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
K82 Other diseases of gallbladder	0.000	0.997	0.003
R72 Abnormality of white blood cells, not elsewhere classified	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
R94.4 Abnormal results of kidney function studies	0.003	0.997	0.000
C83.7 Burkitt's tumour	0.003	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
C92.7 Other myeloid leukaemia	0.003	0.997	0.000
H36.0 Diabetic retinopathy	0.000	0.997	0.003
K76.6 Portal hypertension	0.000	0.997	0.003
K31.9 Disease of stomach and duodenum, unspecified	0.000	0.997	0.003
R94.8 Abnormal results of function studies of other organs and systems	0.003	0.997	0.000
R94.6 Abnormal results of thyroid function studies	0.003	0.997	0.000
R94.7 Abnormal results of other endocrine function studies	0.003	0.997	0.000
D68.5 Primary Thrombophilia	0.003	0.997	0.000
K75 Other inflammatory liver diseases	0.000	0.997	0.003
K70-K77 Diseases of liver	0.000	0.997	0.003
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
C82.0 Small cleaved cell, follicular	0.003	0.997	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.000	0.997	0.003
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
D68.2 Hereditary deficiency of other clotting factors	0.003	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.003	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.003	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.003	0.997	0.000
C82.3 Follicular lymphoma grade IIIa	0.003	0.997	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
T56.8 Other metals	0.003	0.997	0.000
Z99.2 Dependence on renal dialysis	0.000	0.997	0.003
S06.5 Traumatic subdural haemorrhage	0.003	0.997	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
D48.0 Bone and articular cartilage	0.003	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
T56 Toxic effect of metals	0.003	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.997	0.000
C92.3 Myeloid sarcoma	0.002	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.997	0.000
K75.8 Other specified inflammatory liver diseases	0.000	0.997	0.003
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.997	0.000
K75.4 Autoimmune hepatitis	0.000	0.997	0.003
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
K73 Chronic hepatitis, not elsewhere classified	0.000	0.997	0.003
R94.2 Abnormal results of pulmonary function studies	0.002	0.997	0.000
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.002	0.997	0.000
R94.0 Abnormal results of function studies of central nervous system	0.002	0.997	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.997	0.003
C83.1 Small cleaved cell (diffuse)	0.002	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.002	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.997	0.000
I05.9 Mitral valve disease, unspecified	0.003	0.997	0.000
Z63.0 Problems in relationship with spouse or partner	0.003	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.997	0.000
C94.7 Other specified leukaemias	0.002	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.997	0.000
C94.5 Acute myelofibrosis	0.002	0.997	0.000
C94.4 Acute panmyelosis	0.002	0.997	0.000
C94.3 Mast cell leukaemia	0.002	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.997	0.000
C94.1 Chronic erythraemia	0.002	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.997	0.002
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
D68 Other coagulation defects	0.003	0.997	0.000
K82.0 Obstruction of gallbladder	0.000	0.997	0.002
C84.5 Other and unspecified T-cell lymphomas	0.002	0.997	0.000
Z95.4 Presence of other heart-valve replacement	0.002	0.998	0.000
E27.9 Disorder of adrenal gland, unspecified	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.998	0.000
K82.3 Fistula of gallbladder	0.000	0.998	0.002
K82.2 Perforation of gallbladder	0.000	0.998	0.002
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
K80.8 Other cholelithiasis	0.000	0.998	0.002
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
D72 Other disorders of white blood cells	0.002	0.998	0.000
D68.6 Other Thrombophilia	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.002
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.998	0.002
M22.4 Chondromalacia patellae	0.002	0.998	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.998	0.002
K71 Toxic liver disease	0.000	0.998	0.002
K75.9 Inflammatory liver disease, unspecified	0.000	0.998	0.002
K75.2 Nonspecific reactive hepatitis	0.000	0.998	0.002
K75.1 Phlebitis of portal vein	0.000	0.998	0.002
D48.6 Breast	0.002	0.998	0.000
K76 Other diseases of liver	0.000	0.998	0.002
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
K82.1 Hydrops of gallbladder	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.002	0.998	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.998	0.002
K82.9 Disease of gallbladder, unspecified	0.000	0.998	0.002
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
T65 Toxic effect of other and unspecified substances	0.002	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.002	0.998	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.002	0.998	0.000
T60 Toxic effect of pesticides	0.002	0.998	0.000
T57 Toxic effect of other inorganic substances	0.002	0.998	0.000
T54 Toxic effect of corrosive substances	0.002	0.998	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.002	0.998	0.000
T52 Toxic effect of organic solvents	0.002	0.998	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.002	0.998	0.000
T55 Toxic effect of soaps and detergents	0.002	0.998	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.002	0.998	0.000
D68.1 Hereditary factor XI deficiency	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.998	0.002
K75.0 Abscess of liver	0.000	0.998	0.002
K72.9 Hepatic failure, unspecified	0.000	0.998	0.002
T56.9 Metal, unspecified	0.002	0.998	0.000
T56.7 Beryllium and its compounds	0.002	0.998	0.000
T56.6 Tin and its compounds	0.002	0.998	0.000
T56.5 Zinc and its compounds	0.002	0.998	0.000
T56.4 Copper and its compounds	0.002	0.998	0.000
T56.3 Cadmium and its compounds	0.002	0.998	0.000
T56.2 Chromium and its compounds	0.002	0.998	0.000
T56.1 Mercury and its compounds	0.002	0.998	0.000
T56.0 Lead and its compounds	0.002	0.998	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.998	0.002
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.998	0.002
S06 Intracranial injury	0.002	0.998	0.000
K72.1 Chronic hepatic failure	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
O75.0 Maternal distress during labour and delivery	0.002	0.998	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.002	0.998	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.002	0.998	0.000
I45.1 Other and unspecified right bundle-branch block	0.000	0.998	0.002
T58 Toxic effect of carbon monoxide	0.002	0.998	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.998	0.002
D48.7 Other specified sites	0.002	0.998	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.002	0.998	0.000
S06.8 Other intracranial injuries	0.002	0.998	0.000
S72.0 Fracture of neck of femur	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
S06.4 Epidural haemorrhage	0.002	0.998	0.000
Z30 Contraceptive management	0.002	0.998	0.000
D23.5 Skin of trunk	0.002	0.998	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.002	0.998	0.000
D68.0 Von Willebrand's disease	0.002	0.998	0.000
T63 Toxic effect of contact with venomous animals	0.002	0.998	0.000
D72.9 Disorder of white blood cells, unspecified	0.002	0.998	0.000
D72.0 Genetic anomalies of leukocytes	0.002	0.998	0.000
S06.2 Diffuse brain injury	0.002	0.998	0.000
D45 Polycythaemia vera	0.000	0.998	0.002
K71.9 Toxic liver disease, unspecified	0.000	0.998	0.002
K71.8 Toxic liver disease with other disorders of liver	0.000	0.998	0.002
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.998	0.002
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.998	0.002
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.998	0.002
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.998	0.002
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.998	0.002
K71.2 Toxic liver disease with acute hepatitis	0.000	0.998	0.002
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.998	0.002
K71.0 Toxic liver disease with cholestasis	0.000	0.998	0.002
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.998	0.002
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.998	0.002
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.002	0.998	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.002	0.998	0.000
G24.9 Dystonia, unspecified	0.000	0.998	0.002
N90.4 Leukoplakia of vulva	0.002	0.998	0.000
T59 Toxic effect of other gases, fumes and vapours	0.002	0.998	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.002	0.998	0.000
K76.5 Hepatic veno-occlusive disease	0.000	0.998	0.002
K76.4 Peliosis hepatis	0.000	0.998	0.002
K76.3 Infarction of liver	0.000	0.998	0.002
K76.2 Central haemorrhagic necrosis of liver	0.000	0.998	0.002
K76.1 Chronic passive congestion of liver	0.000	0.998	0.002
W22.9 Unspecified place	0.002	0.998	0.000
D68.9 Coagulation defect, unspecified	0.002	0.998	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.002	0.998	0.000
D72.1 Eosinophilia	0.002	0.998	0.000
K76.7 Hepatorenal syndrome	0.000	0.998	0.002
T52.9 Organic solvent, unspecified	0.002	0.998	0.000
T52.8 Other organic solvents	0.002	0.998	0.000
T52.4 Ketones	0.002	0.998	0.000
T52.3 Glycols	0.002	0.998	0.000
T52.2 Homologues of benzene	0.002	0.998	0.000
T52.1 Benzene	0.002	0.998	0.000
T52.0 Petroleum products	0.002	0.998	0.000
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.002	0.998	0.000
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.002	0.998	0.000
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.002	0.998	0.000
T53.5 Chlorofluorocarbons	0.002	0.998	0.000
T53.4 Dichloromethane	0.002	0.998	0.000
T53.3 Tetrachloroethylene	0.002	0.998	0.000
T53.2 Trichloroethylene	0.002	0.998	0.000
T53.1 Chloroform	0.002	0.998	0.000
T53.0 Carbon tetrachloride	0.002	0.998	0.000
T54.9 Corrosive substance, unspecified	0.002	0.998	0.000
T54.3 Corrosive alkalis and alklali-like substances	0.002	0.998	0.000
T54.2 Corrosive acids and acid-like substances	0.002	0.998	0.000
T54.1 Other corrosive organic compounds	0.002	0.998	0.000
T54.0 Phenol and phenol homologues	0.002	0.998	0.000
T57.9 Inorganic substance, unspecified	0.002	0.998	0.000
T57.8 Other specified inorganic substances	0.002	0.998	0.000
T57.3 Hydrogen cyanide	0.002	0.998	0.000
T57.2 Manganese and its compounds	0.002	0.998	0.000
T57.1 Phosphorus and its compounds	0.002	0.998	0.000
T57.0 Arsenic and its compounds	0.002	0.998	0.000
T60.9 Pesticide, unspecified	0.002	0.998	0.000
T60.8 Other pesticides	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations